Liposomes containing bile salts as novel ocular delivery systems for tacrolimus (FK506): in vitro characterization and improved corneal permeation

scientific article published on 14 May 2013

Liposomes containing bile salts as novel ocular delivery systems for tacrolimus (FK506): in vitro characterization and improved corneal permeation is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2147/IJN.S44487
P932PMC publication ID3656938
P698PubMed publication ID23690687
P5875ResearchGate publication ID236924874

P2093author name stringWei Wu
Rui Zhou
Yi Lu
Lin Liu
Jianping Qi
Yikang Dai
P2860cites workRisk factors for corneal graft failure and rejection in penetrating keratoplastyQ74008442
Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in ratsQ79431740
Non-invasive vaccine delivery in transfersomes, niosomes and liposomes: a comparative studyQ81546003
Preparation, characterization and pharmacokinetic studies of tacrolimus-dimethyl-β-cyclodextrin inclusion complex-loaded albumin nanoparticlesQ83425723
Comparative studies of FK506 with cyclosporineQ44965541
Lecithin in mixed micelles attenuates the cytotoxicity of bile salts in Caco-2 cells.Q45064205
Adsorption of mixtures of bile salt taurine conjugates to lecithin-cholesterol membranes: implications for bile salt toxicity and cytoprotection.Q45098192
Liposome coated with low molecular weight chitosan and its potential use in ocular drug delivery.Q45950260
Long term use of topical tacrolimus (FK506) in high-risk penetrating keratoplasty.Q45953545
Enhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile salt.Q46036854
A rapid HPLC-MS/MS method for the simultaneous quantification of cyclosporine A, tacrolimus, sirolimus and everolimus in human blood samplesQ46072595
Effect of topical 0.02% tacrolimus aqueous suspension on tear production in dogs with keratoconjunctivitis siccaQ46594199
Preparation and biopharmaceutical evaluation of tacrolimus loaded biodegradable nanoparticles for liver targeting.Q46626313
Hypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: the effect of cholate type, particle size and administered doseQ47324533
Penetration enhancement of lidocaine hydrochlorid by a novel chitosan coated elastic liposome for transdermal drug delivery.Q48201065
Role of phosphatidylcholine saturation in preventing bile salt toxicity to gastrointestinal epithelia and membranes.Q50676617
Ocular antisense oligonucleotide delivery by cationic nanoemulsion for improved treatment of ocular neovascularization: an in-vivo study in rats and mice.Q54545767
Ocular absorption of topically applied FK506 from liposomal and oil formulations in the rabbit eyeQ72090065
Use of topical FK506 in a corneal graft rejection model in Lewis ratsQ73252880
New surface-active polymers for ophthalmic formulations: evaluation of ocular toleranceQ33203962
Visualization of the penetrative and mucoadhesive properties of chitosan and chitosan-coated liposomes through the rat intestineQ33245789
Integrity and stability of oral liposomes containing bile salts studied in simulated and ex vivo gastrointestinal media.Q34454557
Enhanced oral bioavailability of cyclosporine A by liposomes containing a bile saltQ35071614
Relationships between liposome properties, cell membrane binding, intracellular processing, and intracellular bioavailabilityQ35595798
Octaarginine-modified liposomes: enhanced cellular uptake and controlled intracellular trafficking.Q37074531
Improving oral absorption via drug-loaded nanocarriers: absorption mechanisms, intestinal models and rational fabricationQ38002116
Acidic bile salts modulate the squamous epithelial barrier function by modulating tight junction proteinsQ39535671
Incorporation of liquid lipid in lipid nanoparticles for ocular drug delivery enhancementQ39768121
Establishment of a corneal epithelial cell line spontaneously derived from human limbal cellsQ40183226
Ocular delivery of cyclosporine A based on glyceryl monooleate/poloxamer 407 liquid crystalline nanoparticles: preparation, characterization, in vitro corneal penetration and ocular irritation.Q41612480
Controlled drug release from gels using surfactant aggregates. II. Vesicles formed from mixtures of amphiphilic drugs and oppositely charged surfactantsQ41630591
Liposomes containing glycocholate as potential oral insulin delivery systems: preparation, in vitro characterization, and improved protection against enzymatic degradation.Q41843445
Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: Improving preocular retention and ocular bioavailabilityQ43014361
Flow cytometry as a new approach to investigate drug transfer between lipid particlesQ43197792
P275copyright licenseCreative Commons Attribution-NonCommercial 3.0 UnportedQ18810331
P6216copyright statuscopyrightedQ50423863
P407language of work or nameEnglishQ1860
P304page(s)1921-1933
P577publication date2013-05-14
P1433published inInternational Journal of NanomedicineQ6051502
P1476titleLiposomes containing bile salts as novel ocular delivery systems for tacrolimus (FK506): in vitro characterization and improved corneal permeation
P478volume8